Recruiting

Observational Study

Sponsor:

Nova Scotia Health Authority

Code:

NCT03136302

Conditions

Improving Accuracy of Implanting Stimulation Electrodes

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Interventions

Deep Brain Stimulation

Study Details

Brief summary:

The goal is to establish another anatomical referencing system in order to achieve an even higher accuracy when implanting stimulation electrodes.

Conditions

Improving Accuracy of Implanting Stimulation Electrodes

Study ID

NCT03136302

Start date

Sep 1, 2017

Status verified date

Aug, 2024

Completion date

Sep 1, 2025

Anticipated

Primary completion date

Sep 1, 2025

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Accepted

Inclusion Criteria:

  • Patient qualifying for deep brain stimulation on the basis of a movement disorder (Parkinson's Disease, tremor, dystonia) or chronic pain disease.
  • Informed consent

Exclusion Criteria:

  • Lack of consent
  • Electrical or other devices that preclude the performance of an MRI

Study Design

Enrollment

60 participants

Anticipated

Interventions and Outcome Measures

Arms

Subthalamic Nucleus (STN)

Patients with Parkinson's disease

Globus Pallidus (Gpi)

Patients with Dystonia

Ventral intermediate nucleus of the thalamus (VIM)

Patients with Tremor

Interventions

Deep Brain Stimulation

Deep Brain Stimulation

Primary outcome measure

  • distance between stimulation electrode and motor fibers in mm [ Time Frame: Intraoperative ]

Central Contacts and Locations

Central contacts

Lutz Weise, MD

902-473-6850lutz.weise@nshealth.ca

Locations

Queen Elizabeth Health Science Centre

Recruiting

Halifax, Nova Scotia, Canada, B3H3A7

Contacts

Lutz Weise, MD

902-473-6850lutz.weise@nshealth.ca

More Information

Sponsor

Nova Scotia Health Authority

Last update posted

Aug 21, 2024

Last verified

Aug, 2024

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Nova Scotia Health Authority on 2024-08-21.